ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/18 | 1,626 | 1,643 | 1,590 | 1,634 | -2 | -0.1% | 628,800 |
2021/08/17 | 1,587 | 1,658 | 1,579 | 1,636 | +58 | +3.7% | 617,400 |
2021/08/16 | 1,604 | 1,613 | 1,463 | 1,578 | -66 | -4% | 1,486,700 |
2021/08/13 | 1,636 | 1,666 | 1,625 | 1,644 | +8 | +0.5% | 588,400 |
2021/08/12 | 1,721 | 1,733 | 1,632 | 1,636 | -45 | -2.7% | 933,400 |
2021/08/11 | 1,682 | 1,705 | 1,661 | 1,681 | +13 | +0.8% | 657,900 |
2021/08/10 | 1,624 | 1,670 | 1,614 | 1,668 | +42 | +2.6% | 531,600 |
2021/08/06 | 1,649 | 1,678 | 1,605 | 1,626 | -29 | -1.8% | 670,000 |
2021/08/05 | 1,655 | 1,704 | 1,639 | 1,655 | +19 | +1.2% | 792,000 |
2021/08/04 | 1,695 | 1,698 | 1,617 | 1,636 | -63 | -3.7% | 878,300 |
2021/08/03 | 1,633 | 1,726 | 1,633 | 1,699 | +57 | +3.5% | 1,256,600 |
2021/08/02 | 1,634 | 1,666 | 1,583 | 1,642 | +56 | +3.5% | 1,199,200 |
2021/07/30 | 1,819 | 1,846 | 1,509 | 1,586 | -313 | -16.5% | 6,132,400 |
2021/07/29 | 1,872 | 1,906 | 1,854 | 1,899 | +50 | +2.7% | 600,400 |
2021/07/28 | 1,887 | 1,892 | 1,833 | 1,849 | -52 | -2.7% | 806,400 |
2021/07/27 | 1,934 | 1,945 | 1,894 | 1,901 | -27 | -1.4% | 516,400 |
2021/07/26 | 1,931 | 1,969 | 1,913 | 1,928 | +16 | +0.8% | 391,500 |
2021/07/21 | 1,933 | 1,954 | 1,903 | 1,912 | -11 | -0.6% | 463,500 |
2021/07/20 | 1,910 | 1,960 | 1,910 | 1,923 | -15 | -0.8% | 591,600 |
2021/07/19 | 1,964 | 1,979 | 1,933 | 1,938 | -53 | -2.7% | 534,100 |
2021/07/16 | 1,975 | 1,996 | 1,962 | 1,991 | +11 | +0.6% | 361,300 |
2021/07/15 | 2,014 | 2,020 | 1,980 | 1,980 | -34 | -1.7% | 481,300 |
2021/07/14 | 1,993 | 2,016 | 1,991 | 2,014 | +10 | +0.5% | 310,300 |
2021/07/13 | 2,040 | 2,053 | 1,995 | 2,004 | -45 | -2.2% | 423,900 |
2021/07/12 | 2,049 | 2,067 | 2,034 | 2,049 | +19 | +0.9% | 278,200 |
2021/07/09 | 1,958 | 2,033 | 1,944 | 2,030 | +35 | +1.8% | 677,100 |
2021/07/08 | 1,998 | 2,010 | 1,975 | 1,995 | -14 | -0.7% | 759,800 |
2021/07/07 | 1,997 | 2,015 | 1,983 | 2,009 | -11 | -0.5% | 595,600 |
2021/07/06 | 2,017 | 2,039 | 1,990 | 2,020 | +13 | +0.6% | 407,700 |
2021/07/05 | 2,063 | 2,080 | 2,007 | 2,007 | -64 | -3.1% | 549,900 |
2021/07/02 | 2,063 | 2,101 | 2,057 | 2,071 | +2 | +0.1% | 355,600 |
2021/07/01 | 2,098 | 2,098 | 2,053 | 2,069 | -29 | -1.4% | 442,300 |
2021/06/30 | 2,091 | 2,116 | 2,087 | 2,098 | -8 | -0.4% | 261,600 |
2021/06/29 | 2,129 | 2,157 | 2,092 | 2,106 | -7 | -0.3% | 566,800 |
2021/06/28 | 2,097 | 2,124 | 2,083 | 2,113 | +29 | +1.4% | 344,300 |
2021/06/25 | 2,075 | 2,103 | 2,039 | 2,084 | +18 | +0.9% | 340,100 |
2021/06/24 | 2,087 | 2,126 | 2,058 | 2,066 | -34 | -1.6% | 384,200 |
2021/06/23 | 2,120 | 2,129 | 2,079 | 2,100 | -3 | -0.1% | 304,500 |
2021/06/22 | 2,092 | 2,123 | 2,067 | 2,103 | +59 | +2.9% | 468,600 |
2021/06/21 | 2,065 | 2,087 | 2,020 | 2,044 | -81 | -3.8% | 740,800 |
2021/06/18 | 2,186 | 2,213 | 2,112 | 2,125 | -31 | -1.4% | 717,700 |
2021/06/17 | 2,130 | 2,187 | 2,122 | 2,156 | +9 | +0.4% | 571,600 |
2021/06/16 | 2,158 | 2,176 | 2,118 | 2,147 | -25 | -1.2% | 658,700 |
2021/06/15 | 2,204 | 2,233 | 2,163 | 2,172 | -25 | -1.1% | 618,200 |
2021/06/14 | 2,245 | 2,245 | 2,160 | 2,197 | -37 | -1.7% | 698,500 |
2021/06/11 | 2,325 | 2,330 | 2,226 | 2,234 | -54 | -2.4% | 1,020,600 |
2021/06/10 | 2,277 | 2,308 | 2,234 | 2,288 | -9 | -0.4% | 964,200 |
2021/06/09 | 2,206 | 2,310 | 2,190 | 2,297 | +84 | +3.8% | 1,198,400 |
2021/06/08 | 2,278 | 2,317 | 2,196 | 2,213 | -33 | -1.5% | 1,354,700 |
2021/06/07 | 2,185 | 2,250 | 2,175 | 2,246 | +76 | +3.5% | 730,300 |
901~
950
件表示中 / 3685件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 219,000円 | +21.7% | +999.9% | 0.00% | 9.12倍 | 3.02倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 233,400円 | +14.2% | +41.0% | 1.97% | 11.43倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 307,500円 | +3.0% | +27.5% | 2.60% | 19.47倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 222,400円 | +0.4% | -8.4% | 2.38% | 28.55倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム